Avery Dennison
AVY
166.97
-1.48
-0.88%
Avery Dennison
US · AVY
#1249 by market cap
Listed 1970
166.97
-1.48
-0.88%
Live - 5344 symbols - heartbeat 57s ago
· 2026-10-07 19:54
After-hours
166.97
0.00%
- Market cap
- 12.65B
- P/E (TTM)i
- 18.27
- P/Bi
- 5.45
- EPSi
- 8.79
- Div yieldi
- 2.29%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on AVY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.52, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.14% YoY
Margins
- Gross margin
- 28.75%
- Operating margin
- 12.69%
- Net margin
- 7.77%
Key ratios & quality
- Enterprise valuei
- 16.18B
- Altman Z-Scorei
- 3.52
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.16B | 7.07B | 6.97B | 8.41B | 9.04B | 8.36B | 8.76B | 8.86B |
| Gross profit | 1.92B | 1.90B | 1.92B | 2.31B | 2.40B | 2.28B | 2.53B | 2.55B |
| Selling & admin expenses | 1.13B | 1.08B | 1.06B | 1.11B | 1.19B | 1.18B | 1.28B | 1.29B |
| Research & development | -- | -- | -- | 136.60M | 136.10M | 135.80M | 137.80M | 136.60M |
| Operating profit | 788.00M | 823.70M | 862.80M | 1.06B | 1.07B | 963.80M | 1.12B | 1.12B |
| Pretax profit | 554.80M | 249.50M | 737.30M | 992.60M | 999.30M | 694.70M | 953.50M | 925.10M |
| Tax | 85.40M | -56.70M | 177.70M | 248.60M | 242.20M | 191.70M | 248.60M | 237.10M |
| Net profit | 467.40M | 303.60M | 555.90M | 740.10M | 757.10M | 503.00M | 704.90M | 688.00M |
| Basic EPS | 5 | 4 | 7 | 9 | 9 | 6 | 9 | 9 |
| Diluted EPS | 5.28 | 3.57 | 6.61 | 8.83 | 9.21 | 6.20 | 8.73 | 8.79 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.15B | 2.22B | 2.22B | 2.27B | 2.30B | 2.46B |
| Gross profit | 621.50M | 639.10M | 635.00M | 650.70M | 664.80M | 729.40M |
| Selling & admin expenses | 347.00M | 352.40M | 353.90M | 232.60M | 375.10M | 394.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 274.50M | 286.70M | 281.10M | 281.50M | 289.70M | 334.60M |
| Pretax profit | 227.00M | 255.50M | 234.80M | 207.80M | 240.40M | 282.70M |
| Tax | 60.70M | 66.50M | 68.50M | 41.40M | 72.30M | 78.60M |
| Net profit | 166.30M | 189.00M | 166.30M | 166.40M | 168.10M | 204.10M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 2.09 | 2.41 | 2.13 | 2.15 | 2.18 | 2.67 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.30B | 2.34B | 2.42B | 2.73B | 2.78B | 2.80B | 3.08B | 2.99B |
| Cash & ST investments | 232.00M | 253.70M | 252.30M | 162.70M | 167.20M | 215.00M | 329.10M | 202.80M |
| Inventory | 651.40M | 663.00M | 717.20M | 907.20M | 1.01B | 920.70M | 978.10M | 975.80M |
| Total assets | 5.18B | 5.49B | 6.08B | 7.97B | 7.95B | 8.21B | 8.40B | 8.80B |
| Total current liabilities | 1.99B | 2.25B | 1.93B | 2.55B | 2.80B | 2.70B | 2.86B | 2.65B |
| Short-term debt | 194.60M | 440.20M | 64.70M | 318.80M | 598.60M | 622.20M | 592.30M | 522.90M |
| Long-term debt | 1.77B | 1.50B | 2.05B | 2.79B | 2.50B | 2.62B | 2.56B | 3.21B |
| Total liabilities | 4,222,400,000.00 | 4,284,800,000.00 | 4,599,000,000.00 | 6,047,200,000.00 | 5,918,300,000.00 | 6,081,900,000.00 | 6,091,900,000.00 | 6,559,600,000.00 |
| Total equity | 955.10M | 1.20B | 1.48B | 1.92B | 2.03B | 2.13B | 2.31B | 2.24B |
| Retained earnings | 2.86B | 2.98B | 3.35B | 3.88B | 4.41B | 4.69B | 5.15B | 5.60B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.03B | 3.18B | 3.52B | 2.99B | 3.22B | 3.40B |
| Cash & ST investments | 195.90M | 215.90M | 536.30M | 202.80M | 255.10M | 227.30M |
| Inventory | 1.02B | 1.03B | 1.04B | 975.80M | 989.40M | 1.03B |
| Total assets | 8.35B | 8.57B | 8.87B | 8.80B | 8.98B | 9.21B |
| Total current liabilities | 2.95B | 3.06B | 2.79B | 2.65B | 2.80B | 3.01B |
| Short-term debt | 877.50M | 922.00M | 578.80M | 522.90M | 605.00M | 500.50M |
| Long-term debt | 2.58B | 2.63B | 3.20B | 3.21B | 3.19B | 3.18B |
| Total liabilities | 6,184,200,000.00 | 6,366,600,000.00 | 6,655,900,000.00 | 6,559,600,000.00 | 6,678,100,000.00 | 6,889,500,000.00 |
| Total equity | 2.17B | 2.20B | 2.21B | 2.24B | 2.30B | 2.32B |
| Retained earnings | 5.28B | 5.40B | 5.50B | 5.60B | 5.71B | 5.84B |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 457.90M | 746.50M | 751.30M | 1.05B | 961.00M | 826.00M | 938.80M | 881.40M |
| Depreciation & amortization | 181.00M | 179.00M | 205.30M | 244.10M | 290.70M | 298.40M | 312.20M | 328.20M |
| Free cash flow | 201.30M | 489.30M | 532.70M | 774.70M | 662.50M | 540.90M | 699.00M | 681.00M |
| Dividends paid | -175.00M | -189.70M | -196.80M | -220.60M | -238.90M | -256.70M | -277.50M | -288.40M |
| Stock buybacks / issuance | -392.90M | -237.70M | -104.30M | -180.90M | -379.50M | -137.50M | -247.50M | -572.30M |
| Ending cash balance | 232.00M | 253.70M | 252.30M | 162.70M | 167.20M | 215.00M | 329.10M | 202.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -16.30M | 208.80M | 312.10M | 376.80M | 136.50M | 408.20M |
| Depreciation & amortization | 77.90M | 80.80M | 84.00M | 85.50M | 86.80M | 86.40M |
| Free cash flow | -59.90M | 171.20M | 268.50M | 301.20M | 100.50M | 362.80M |
| Dividends paid | -69.40M | -73.50M | -73.10M | -72.40M | -72.30M | -76.20M |
| Stock buybacks / issuance | -261.60M | -98.40M | -93.60M | -118.70M | -60.60M | -137.60M |
| Ending cash balance | 195.90M | 215.90M | 536.30M | 202.80M | 255.10M | 227.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 46.71 | 28.12 | 41.35 | 43.42 | 38.27 | 24.18 | 31.75 | 30.21 |
| ROA %i | 9.06 | 5.69 | 9.61 | 10.53 | 9.51 | 6.23 | 8.49 | 8.00 |
| ROIC %i | 18.63 | 11.84 | 18.06 | 18.37 | 16.15 | 11.22 | 14.61 | 13.79 |
| 5-year avg ROE %i | 31.15 | 32.92 | 35.74 | 37.64 | 39.57 | 35.07 | 35.79 | 33.57 |
| EBIT margin %i | 8.57 | 4.60 | 11.58 | 12.64 | 11.99 | 9.73 | 12.23 | 11.98 |
| FCF / sales %i | 2.81 | 6.92 | 7.64 | 9.21 | 7.33 | 6.47 | 7.98 | 7.69 |
| Current ratioi | 1.15 | 1.04 | 1.25 | 1.07 | 0.99 | 1.04 | 1.08 | 1.13 |
| Quick ratioi | 0.71 | 0.65 | 0.77 | 0.62 | 0.55 | 0.60 | 0.63 | 0.64 |
| Debt / assetsi | 37.98 | 35.34 | 34.79 | 38.95 | 39.02 | 39.52 | 37.51 | 42.41 |
| LT debt / equityi | 185.49 | 124.53 | 138.20 | 144.77 | 123.19 | 123.22 | 110.71 | 143.17 |
| Interest coveragei | 10.48 | 4.29 | 11.53 | 15.14 | 12.88 | 6.84 | 9.15 | 7.83 |
| Revenue CAGR (3Y) %i | 6.26 | 5.12 | 1.77 | 5.51 | 8.54 | 6.26 | 1.36 | -0.68 |
| Net income CAGR (3Y) %i | 19.44 | -1.81 | 25.42 | 16.56 | 35.61 | -3.28 | -1.61 | -3.14 |
| FCF CAGR (3Y) %i | -14.51 | 9.22 | 8.28 | 56.71 | 10.63 | 0.51 | -3.37 | 0.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 31.95 | 31.68 | 30.21 | 30.21 | 30.86 | 31.16 |
| ROA %i | 8.41 | 8.43 | 8.03 | 8.00 | 7.96 | 7.93 |
| ROIC %i | 14.21 | 14.26 | 13.65 | 13.79 | 13.53 | 13.76 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.17 | 12.44 | 12.38 | 11.98 | 11.98 | 11.98 |
| FCF / sales %i | 6.57 | 6.89 | 7.44 | 7.69 | 9.34 | 11.17 |
| Current ratioi | 1.03 | 1.04 | 1.26 | 1.13 | 1.15 | 1.13 |
| Quick ratioi | 0.58 | 0.60 | 0.78 | 0.64 | 0.68 | 0.67 |
| Debt / assetsi | 41.40 | 41.43 | 42.64 | 42.41 | 42.21 | 39.93 |
| LT debt / equityi | 118.94 | 119.38 | 144.83 | 143.17 | 138.45 | 136.80 |
| Interest coveragei | 8.93 | 8.76 | 8.53 | 7.83 | 7.70 | 7.80 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Materials Group is the largest reported line at 72.93% of revenue, across 2 reported segments.
- The next-largest line, Solutions Group, is a distant second at 27.07% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Materials Group72.93%
Solutions Group27.07%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.